← FDA Drug Approvals (Drugs@FDA)

BIMATOPROST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2019-06-19

Drug application

FDA Application #

ANDA207601

Application type

Abbreviated New Drug Application (Generic)

Brand name

BIMATOPROST

Generic name

BIMATOPROST

Active ingredients

BIMATOPROST

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

SOMERSET THERAPS LLC

Manufacturer

Somerset Therapeutics, LLC

First approval

2019-06-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown